Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
READ: Docetaxel-Cyclophosphamide vs Epirubicin-Cyclophosphamide-Docetaxel in Early Breast Cancer
NCT00689156Phase 3Completed
- Sponsor
- Danish Breast Cancer Cooperative Group
- Start
- Jun 2008
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel, cyclophosphamide in breast cancer, sponsored by Danish Breast Cancer Cooperative Group. Started Jun 2008; status: completed.
02
Drugs
docetaxelcyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00689156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00689156.